A. Gringeri

A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study

Jan Astermark, Sharyne Donfield, Donna DiMichele et al. · Blood · 2006 · 467 citations · Full text

A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)

A. Gringeri, Björn Lundin, Sylvia von Mackensen et al. · Journal of Thrombosis and Haemostasis · 2011 · 447 citations · Full text

Randomized Clinical Trial, Pediatric Epidemiology, Pediatric Hematology +5

Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group

A. Gringeri, LG Mantovani, L Scalone et al. · Blood · 2003 · 367 citations

Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo.

John J. Costa, George D. Demetri, Terence J. Harrist et al. · The Journal of Experimental Medicine · 1996 · 271 citations · Full text

Mast Cell Disorder, Adult Stem Cell, Immunology +25

Consensus perspectives on prophylactic therapy for haemophilia: summary statement

Erik Berntorp, Jan Astermark, Sven Björkman et al. · Haemophilia · 2003 · 270 citations · Full text

Consensus Summary, Preventive Medicine, Secondary Prophylaxis +14